Elekta posts net income of SEK63m for half year May to October 2014
M2 - Fri Nov 28, 3:44AM CST
Human care company Elekta AB (STO:EKTAB.ST) on Thursday reported net income of SEK63m, or diluted EPS of SEK0.16, for the period May to October 2014, of fiscal year 2014/15.
Elekta announces inclusion in FTSE4Good Index Series
M2 - Thu Oct 09, 6:34AM CDT
Human care company Elekta AB (STO:EKTAB) announced on Wednesday its addition to the FTSE4Good Index Series (http://www.ftse.com/products/indices/FTSE4Good).
Elekta announces share acquisition by President and CEO
M2 - Fri Oct 03, 5:07AM CDT
Human care company Elekta AB (STO: EKTAB) announced on Thursday the acquisition by Niklas Savander, president and CEO of Elekta, of 14,080 shares in the company.
Elekta's Versa HD radiation therapy system now available in China
M2 - Mon Sep 29, 5:19AM CDT
Human care company Elekta AB (STO:EKTAB) announced on Monday, that following US and European approvals of Elekta's Versa HD linear accelerator, the China Food and Drug Administration (CFDA) has cleared the radiation therapy system for sale and marketing in the country.
Elekta announces availability of Versa HD Radiation Therapy System in Japan for treatment of cancer patients
M2 - Tue Sep 02, 3:06AM CDT
Human care company Elekta AB (STO:EKTAB.ST) announced today the availability of its Versa HD Radiation Therapy Systems in Japan for the treatment of cancer.
Elekta to acquire RTA in Poland
M2 - Mon Aug 25, 5:43AM CDT
Human care company Elekta AB (STO:EKTAB.ST) today announced that it intends to acquire RTA, a distributor from Poland specialising in cutting-edge radiation therapy technologies.
Elekta acquires Mesi Medikal in Turkey
M2 - Thu Jul 24, 6:32AM CDT
Human care company Elekta AB (STO:EKTAB.ST) announced today the acquisition of Mesi Medikal A.S, a distributor of radiation oncology solutions in Turkey.